Franklin Resources’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.35M Sell
155,241
-17,491
-10% -$377K ﹤0.01% 1513
2025
Q1
$2.87M Sell
172,732
-8,136
-4% -$135K ﹤0.01% 1561
2024
Q4
$3.32M Sell
180,868
-8,097
-4% -$149K ﹤0.01% 1525
2024
Q3
$2.83M Sell
188,965
-227
-0.1% -$3.4K ﹤0.01% 1599
2024
Q2
$3.07M Buy
189,192
+40,711
+27% +$662K ﹤0.01% 1535
2024
Q1
$2.75M Buy
148,481
+98,076
+195% +$1.81M ﹤0.01% 1592
2023
Q4
$1.58M Buy
50,405
+803
+2% +$25.1K ﹤0.01% 1470
2023
Q3
$1.03M Buy
49,602
+2,198
+5% +$45.8K ﹤0.01% 1605
2023
Q2
$1.14M Buy
47,404
+16,578
+54% +$397K ﹤0.01% 1588
2023
Q1
$580K Sell
30,826
-505
-2% -$9.5K ﹤0.01% 1637
2022
Q4
$499K Sell
31,331
-436
-1% -$6.94K ﹤0.01% 1697
2022
Q3
$520K Buy
31,767
+16,735
+111% +$274K ﹤0.01% 1672
2022
Q2
$212K Sell
15,032
-3,084
-17% -$43.5K ﹤0.01% 2005
2022
Q1
$439K Buy
18,116
+1,368
+8% +$33.2K ﹤0.01% 1876
2021
Q4
$391K Buy
+16,748
New +$391K ﹤0.01% 1995
2021
Q3
Sell
-711,711
Closed -$17.4M 2447
2021
Q2
$17.4M Buy
711,711
+2,047
+0.3% +$49.9K 0.01% 889
2021
Q1
$18.3M Sell
709,664
-768
-0.1% -$19.8K 0.01% 853
2020
Q4
$38M Buy
710,432
+627
+0.1% +$33.5K 0.02% 664
2020
Q3
$29.3M Buy
709,805
+33,215
+5% +$1.37M 0.01% 673
2020
Q2
$29M Hold
676,590
0.02% 651
2020
Q1
$28.6M Hold
676,590
0.02% 592
2019
Q4
$28.9M Sell
676,590
-73,200
-10% -$3.13M 0.02% 679
2019
Q3
$27M Hold
749,790
0.01% 677
2019
Q2
$20M Hold
749,790
0.01% 747
2019
Q1
$20.1M Buy
749,790
+719,396
+2,367% +$19.3M 0.01% 745
2018
Q4
$491K Buy
+30,394
New +$491K ﹤0.01% 1328
2018
Q2
Sell
-2,166,346
Closed -$48.7M 1462
2018
Q1
$48.7M Sell
2,166,346
-1,071,500
-33% -$24.1M 0.02% 543
2017
Q4
$97.5M Buy
3,237,846
+169,057
+6% +$5.09M 0.05% 371
2017
Q3
$116M Sell
3,068,789
-501,100
-14% -$18.9M 0.06% 329
2017
Q2
$99.6M Sell
3,569,889
-86,560
-2% -$2.41M 0.05% 362
2017
Q1
$126M Sell
3,656,449
-565,340
-13% -$19.4M 0.06% 309
2016
Q4
$122M Buy
4,221,789
+46,003
+1% +$1.33M 0.06% 297
2016
Q3
$133M Buy
4,175,786
+809,100
+24% +$25.7M 0.07% 285
2016
Q2
$109M Buy
3,366,686
+778,269
+30% +$25.3M 0.06% 328
2016
Q1
$72.4M Buy
2,588,417
+760,484
+42% +$21.3M 0.04% 425
2015
Q4
$65.2M Buy
1,827,933
+89,180
+5% +$3.18M 0.03% 477
2015
Q3
$57.5M Sell
1,738,753
-741,800
-30% -$24.5M 0.03% 510
2015
Q2
$104M Buy
2,480,553
+393,553
+19% +$16.5M 0.05% 381
2015
Q1
$68M Buy
2,087,000
+753,500
+57% +$24.6M 0.03% 506
2014
Q4
$42.3M Sell
1,333,500
-148,900
-10% -$4.73M 0.02% 650
2014
Q3
$36.7M Sell
1,482,400
-642,200
-30% -$15.9M 0.02% 695
2014
Q2
$48M Buy
2,124,600
+879,800
+71% +$19.9M 0.02% 612
2014
Q1
$30.3M Sell
1,244,800
-121,000
-9% -$2.94M 0.01% 744
2013
Q4
$34.1M Buy
1,365,800
+256,800
+23% +$6.42M 0.02% 665
2013
Q3
$30.5M Buy
1,109,000
+148,800
+15% +$4.09M 0.02% 690
2013
Q2
$17.4M Buy
+960,200
New +$17.4M 0.01% 794